Showing 581-590 of 2538 results for "".
A Matter of Time: An Update on Interventional Stroke Research
https://practicalneurology.com/diseases-diagnoses/imaging-testing/a-matter-of-time-an-update-on-interventional-stroke-research/30756/New advancements suggest enhanced opportunities to improve outcomes and save lives. Experts weigh in.Headache Horizons: Headaches That Roam the Night
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-horizons-headaches-that-roam-the-night/31636/Many headache types can occur in the night, including some that may be exclusive to dream periods.News
https://practicalneurology.com/archives/2016-nov-dec/news/30402/Building the Ideal Stroke Network With Telemedicine
https://practicalneurology.com/diseases-diagnoses/stroke/building-the-ideal-stroke-network-with-telemedicine/30451/Telemedicine is the glue that holds stroke networks together.Ocrelizumab and the Next Phase in Multiple Sclerosis Therapy
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ocrelizumab-and-the-next-phase-in-multiple-sclerosis-therapy/30505/Advances in immune therapy may change how scientists and clinicians understand neurodegenerative components of MS.Perampanel: Novel Mechanism for the Management of Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/perampanel-novel-mechanism-for-the-management-of-epilepsy/30645/An epilepsy specialist reviews the role of a new AMPA receptor agonist for epilepsy.Hometown Highlights: Clinical Experience Treating Adults With Spinal Muscular Atrophy
https://practicalneurology.com/diseases-diagnoses/neuromuscular/hometown-highlights-clinical-experience/30162/Treating adult patients with antisense oligonucleotide therapy proven effective in children presents unique challenges.ECTRIMS Data Signal Renewed Emphasis on Multiple Sclerosis Disease Progression, Disability
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ectrims-data-signal-renewed-emphasis-on-multiple-sclerosis-disease-progression-disability/30301/New Guidelines Update Approach to Episodic Migraine Prevention
https://practicalneurology.com/diseases-diagnoses/headache-pain/new-guidelines-update-approach-to-episodic-migraine-prevention/30770/Only a small percentage of patients who may be eligible for it report current use of daily preventive migraine medication. New guidelines may increase access.Neurology Clinical Trials in the Community Hospital Setting
https://practicalneurology.com/columns/practice-management/neurology-clinical-trials-in-the-community-hospital-setting/30850/A significant trend, encouraged by NIH, is expanding clinical research to community hospitals with potential benefits for patients and clinicians.